From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

What if we captured the spirit and urgency of Covid-19 research to cure cancer?

In recent months, scientists and policymakers around the globe have rallied together with one common goal: to eliminate Covid-19.

Vaccine hesitancy part 2: Effective strategies for a human-centered health campaign - Atlantic Council

Trust is health’s most valuable player COVID-19 has made clear that the 

Leading Health Care and Infectious Disease Experts Join Together to Discuss COVID-19 Vaccine Safety, Equity and Distribution - Associated Press

December 17, 2020 (Washington, D.C.) As Americans patiently await their turn for COVID-19 vaccination, a group of leading medical, health equity and public policy experts discussed and an

US Agency Grants Approval of Pfizer's COVID Vaccine And Doses Are Expected in Days - Science Alert

US regulators have authorised the first coronavirus vaccine for emergency use, marking an inflection point in the 

Countdown to a Coronavirus Vaccine - The New Yorker

On a hot afternoon in August, Debbie Honeycutt walked into the crowded waiting room of the Medical Center for Clinical Research, an experimental-treatment facility tucked inside a squat office building in San Diego.

Michael J. Fox Foundation for Parkinson's Research Honored with Advocacy/Policy Award from Reagan-Udall Foundation for the FDA - PR Newswire

NEW YORK, Dec. 9, 2020 /PRNewswire/ -- The Michael J.

Surescripts Fireside Chat with Dr. Amy Abernethy, Principal Deputy Commissioner and Acting CIO, FDA

Tom Skelton, CEO of Surescripts, recently spoke with Dr. Amy Abernethy of the FDA, about the impact of COVID-19 and the evolving data needs of public health.    

FDA’s Amy Abernethy, Friends of Cancer Research, and The Michael J. Fox Foundation for Parkinson’s Research Honored with Innovations in Regulatory Science Awards

Honorees to be recognized virtually on December 8, 2020

We may soon have a COVID-19 vaccine. But will enough people take it? - Reuters

ZURICH/LONDON (Reuters) - With COVID-19 vaccine trial results looking positive, governments and pharmaceutical firms face their next daunting challenge: convincing the world to get inoculated.

In Brief - The Cancer Letter

Reagan-Udall receives $250,000 from Rockefeller Foundation for COVID-19 Diagnostics Evidence Accelerator